Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.80
Bid: 111.40
Ask: 112.60
Change: -1.60 (-1.41%)
Spread: 1.20 (1.077%)
Open: 113.40
High: 113.60
Low: 111.00
Prev. Close: 113.40
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Day Highlights

15 Jan 2015 07:00

RNS Number : 1984C
SAGA PLC
15 January 2015
 

 

Saga plc

Capital Markets Day

15 January 2015

 

Capital Markets Day Highlights

 

· Creation of Saga Investment Services, a wealth management partnership with Tilney Bestinvest

· Renewed focus on growth initiatives in Saga's existing businesses

· Intention to launch motor broking panel to broaden accessible client base

· Decision to divest Saga's local authority section of its healthcare business, Allied Healthcare, and focus on privately funded healthcare

· Trading for 2014/2015 in line with market expectations and the dividend is expected to be at the top end of the forecast pay-out range

 

Saga plc ("Saga") is today holding a Capital Markets Day to update investors and analysts on the company's strategy. The presentation will be made available at corporate.saga.co.uk this morning.

 

Lance Batchelor, Group Chief Executive Officer, commented:

 

"In the ten months that I have led the business, I have seen the depth of insight into our core demographic that our unique database provides, the potential of our brand, the consistent performance of the Group - in particular our insurance business - and the quality of our people.

 

"I am very clear that our model is predominantly that of a broker, accessing the best products for our customers and delivering them with our own high standards of customer service. This model works best when superior customer knowledge and a trusted brand work together to create a competitive edge, helping to build enduring relationships directly with our customers.

 

"The strategy that we outline today shows how we intend to use these competitive strengths to unlock the potential of our existing businesses and to continue to explore new areas of growth, while maintaining our capital-light, cash-generative operating model. This will drive growth in our existing businesses, provide scope for investment in new products and underpin a progressive dividend policy."

 

Wealth Management

 

Following a comprehensive review of the wealth management marketplace, Saga announces the creation of Saga Investment Services, powered by Tilney Bestinvest. The joint venture will draw on our respective strengths to deliver a compelling wealth and investment proposition for Saga customers. Saga's insight into the needs of the UK's over 50s will inform and drive proposition design and customer experience, while Tilney Bestinvest will provide investment and financial planning expertise.

 

Healthcare

 

As part of its strategic review, Saga has decided to focus on privately funded homecare where Saga has a relationship directly with the customer. A dedicated management team is running this part of the business, including the Patricia White's, Country Cousins and Saga SOS branded businesses and the pilot in Private Pay Homecare.

 

As a result, the parts of the Allied Healthcare business focussed on Local Authorities and the NHS do not fit with the Saga business model and the decision has been taken to divest this part of the business. Saga remains absolutely committed to delivering excellent standards of care to Allied Healthcare's customers during this period. A further update will be provided in due course.

 

Growing our existing businesses

 

· In Saga's Insurance business, growth will be driven primarily through broking, while maintaining a targeted underwriting exposure in areas where there is a track record of strong and consistent profitability based on Saga's access to superior customer data.

 

· Saga today announces the intention to launch a new motor panel to broaden the accessible client base without assuming any incremental underwriting risk. Saga has achieved excellent results with this approach in its Home Insurance business and it will enable Saga to offer competitive quotes to Saga customers that currently sit outside our core underwriting activities.

 

· In Travel, Saga aims to double EBITDA within five years from January 2014 by further diversifying its offer to include a greater range of third-party products alongside its own to target different groups of customers more effectively, while also diversifying distribution channels.

 

Further New Initiatives

 

· Saga Legal Services is now operational with more than 8,000 customers.

 

· Saga also announces today that it has signed a partnership with Spire Healthcare, to pilot a 'home from hospital service', which will enable patients to be discharged earlier from hospital and help them to resettle at home after a hospital stay.

 

· Saga continues to work with its partner, Rangeford, on the Wadswick Green retirement village pilot development in Wiltshire. 

 

Trading Update for 2014/15 Preliminary Results

 

· Trading is in line with market expectations.

 

· The dividend for 2014/15 is anticipated to be at the top end of the targeted 40-50% pay-out range, highlighting our progressive dividend policy.

 

· The Group will seek to maximise returns for investors by optimising the balance between investment, dividends and debt reduction.

 

· Allied will no longer be presented as part of the continuing operations and will give rise to a one-off write-down of goodwill and potentially other related balance sheet items, the amount of which will be determined over the coming months.

 

Appendix I contains the interim results of the business for the period to 31 July 2014 presented to exclude the Allied Healthcare business to be divested.

 

ENDS

 

For further information, please contact:

 

 

 

Saga plc

 

Tim McCall - Director of Corporate AffairsDuncan Browne - Investor Relations Manager

+ 44 (0) 20 7654 2729 tim.mccall@saga.co.uk+44 (0) 77 1044 0528duncan.browne@saga.co.uk

 

 

FTI Consulting

 

Paul Marriott / Lucinda Kemeny

+44 (0) 20 3727 1341 / 1580

paul.marriott@fticonsulting.com lucinda.kemeny@fticonsulting.com

 

 

Appendix I

 

Interim results of the business for the period to 31 July 2014 presented to exclude the Allied Healthcare business to be divested.

 

Continuing Operations

As Reported

£m

6m toJul 2014

6m toJul 2013

12m toJan 2014

6m toJul 2014

6m toJul 2013

12m toJan 2014

Revenue

440.1

447.7

895.5

583.5

607.1

1,209.3

Trading EBITDA

129.6

118.7

214.8

130.4

118.9

222.4

Operating profit

116.3

104.9

182.4

110.0

95.5

169.6

PBT (like-for-like)

115.9

105.3

167.9

106.5

92.7

146.5

Revenue growth

(1.7%)

(3.9%)

Trading EBITDA growth

9.2%

9.7%

Operating profit %

26.4%

23.4%

20.4%

18.9%

15.7%

14.0%

Intangibles amortisation

(0.1)

(0.1)

(0.1)

(5.2)

(8.0)

(17.8)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUCWGUPAGMC
Date   Source Headline
7th May 20244:32 pmRNSTotal Voting Rights
30th Apr 20249:15 amRNSIssue of Equity
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.